US Stock MarketDetailed Quotes

SABSW SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM)

Watchlist
  • 0.0254
  • 0.00000.00%
Close Aug 19 16:00 ET
0Market Cap0.00P/E (TTM)

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
57.52%10.2M
53.89%11.39M
31.67%38.08M
140.12%18.87M
-31.82%5.32M
-1.01%6.48M
10.36%7.4M
115.91%28.92M
7.02%7.86M
95.65%7.81M
Selling and administrative expenses
25.61%3.64M
21.52%4.19M
45.27%23.8M
416.22%14.88M
-36.44%2.57M
-32.70%2.9M
-33.53%3.45M
-4.11%16.38M
-62.82%2.88M
12.31%4.04M
-General and administrative expense
25.61%3.64M
21.52%4.19M
45.27%23.8M
416.22%14.88M
-36.44%2.57M
-32.70%2.9M
-33.53%3.45M
-4.11%16.38M
-62.82%2.88M
12.31%4.04M
Research and development costs
86.29%6.82M
79.60%8.15M
-54.68%16.52M
-39.80%4.3M
-45.33%4.02M
-57.34%3.66M
-65.96%4.54M
-36.28%36.44M
-32.96%7.14M
-51.21%7.35M
Other operating expenses
-207.70%-263.14K
-62.55%-944.58K
90.63%-2.24M
85.88%-305.01K
64.69%-1.27M
98.65%-85.52K
95.08%-581.1K
60.73%-23.9M
80.46%-2.16M
75.55%-3.59M
Operating profit
-57.52%-10.2M
-53.89%-11.39M
-31.67%-38.08M
-140.12%-18.87M
31.82%-5.32M
1.01%-6.48M
-245.26%-7.4M
-115.91%-28.92M
-7.02%-7.86M
-95.65%-7.81M
Net non-operating interest income expense
701.98%281.44K
1,325.46%421.52K
216.99%269.68K
803.08%406.17K
-3.93%-55.34K
15.63%-46.75K
46.33%-34.4K
15.05%-230.51K
-0.07%-57.77K
28.81%-53.24K
Non-operating interest income
1,211.11%374.56K
758.61%497.89K
723.06%584.97K
1,517.31%484.05K
-17.38%14.36K
80.54%28.57K
630.97%57.99K
207.47%71.07K
250.29%29.93K
361.26%17.39K
Non-operating interest expense
23.63%93.12K
-17.33%76.37K
4.54%315.28K
-11.20%77.88K
-1.31%69.7K
5.73%75.32K
28.27%92.39K
2.42%301.58K
32.33%87.7K
-10.10%70.63K
Other net income (expense)
822.99%2.58M
7,096.56%5.94M
-142.06%-4.39M
-6,478.39%-4.39M
-64.83%275.94K
-120.66%-357.52K
-98.95%82.59K
399.80%10.43M
101.66%68.81K
19,745.41%784.49K
Gain on sale of security
720.10%2.22M
6,521.24%5.47M
-146.38%-4.82M
-13,020.42%-4.73M
-77.17%178.76K
-120.66%-357.52K
-98.95%82.59K
350.52%10.4M
--36.59K
--782.96K
Other non- operating income (expenses)
--367.83K
--475.13K
1,189.00%435.09K
948.52%337.91K
6,264.31%97.18K
----
----
515.05%33.75K
1,999.48%32.23K
-61.37%1.53K
Income before tax
-6.61%-7.34M
31.66%-5.03M
-125.45%-42.19M
-191.21%-22.86M
27.89%-5.1M
-41.34%-6.88M
-782.08%-7.35M
-9.16%-18.72M
32.05%-7.85M
-74.24%-7.08M
Income tax
0
25.63K
Net income
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
-74.24%-7.08M
Net income continuous Operations
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
-74.24%-7.08M
Minority interest income
Net income attributable to the parent company
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
-74.24%-7.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
-74.24%-7.08M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 57.52%10.2M53.89%11.39M31.67%38.08M140.12%18.87M-31.82%5.32M-1.01%6.48M10.36%7.4M115.91%28.92M7.02%7.86M95.65%7.81M
Selling and administrative expenses 25.61%3.64M21.52%4.19M45.27%23.8M416.22%14.88M-36.44%2.57M-32.70%2.9M-33.53%3.45M-4.11%16.38M-62.82%2.88M12.31%4.04M
-General and administrative expense 25.61%3.64M21.52%4.19M45.27%23.8M416.22%14.88M-36.44%2.57M-32.70%2.9M-33.53%3.45M-4.11%16.38M-62.82%2.88M12.31%4.04M
Research and development costs 86.29%6.82M79.60%8.15M-54.68%16.52M-39.80%4.3M-45.33%4.02M-57.34%3.66M-65.96%4.54M-36.28%36.44M-32.96%7.14M-51.21%7.35M
Other operating expenses -207.70%-263.14K-62.55%-944.58K90.63%-2.24M85.88%-305.01K64.69%-1.27M98.65%-85.52K95.08%-581.1K60.73%-23.9M80.46%-2.16M75.55%-3.59M
Operating profit -57.52%-10.2M-53.89%-11.39M-31.67%-38.08M-140.12%-18.87M31.82%-5.32M1.01%-6.48M-245.26%-7.4M-115.91%-28.92M-7.02%-7.86M-95.65%-7.81M
Net non-operating interest income expense 701.98%281.44K1,325.46%421.52K216.99%269.68K803.08%406.17K-3.93%-55.34K15.63%-46.75K46.33%-34.4K15.05%-230.51K-0.07%-57.77K28.81%-53.24K
Non-operating interest income 1,211.11%374.56K758.61%497.89K723.06%584.97K1,517.31%484.05K-17.38%14.36K80.54%28.57K630.97%57.99K207.47%71.07K250.29%29.93K361.26%17.39K
Non-operating interest expense 23.63%93.12K-17.33%76.37K4.54%315.28K-11.20%77.88K-1.31%69.7K5.73%75.32K28.27%92.39K2.42%301.58K32.33%87.7K-10.10%70.63K
Other net income (expense) 822.99%2.58M7,096.56%5.94M-142.06%-4.39M-6,478.39%-4.39M-64.83%275.94K-120.66%-357.52K-98.95%82.59K399.80%10.43M101.66%68.81K19,745.41%784.49K
Gain on sale of security 720.10%2.22M6,521.24%5.47M-146.38%-4.82M-13,020.42%-4.73M-77.17%178.76K-120.66%-357.52K-98.95%82.59K350.52%10.4M--36.59K--782.96K
Other non- operating income (expenses) --367.83K--475.13K1,189.00%435.09K948.52%337.91K6,264.31%97.18K--------515.05%33.75K1,999.48%32.23K-61.37%1.53K
Income before tax -6.61%-7.34M31.66%-5.03M-125.45%-42.19M-191.21%-22.86M27.89%-5.1M-41.34%-6.88M-782.08%-7.35M-9.16%-18.72M32.05%-7.85M-74.24%-7.08M
Income tax 025.63K
Net income -6.61%-7.34M31.66%-5.03M-125.14%-42.19M-190.26%-22.86M27.89%-5.1M-44.07%-6.88M-845.93%-7.35M-9.31%-18.74M31.83%-7.87M-74.24%-7.08M
Net income continuous Operations -6.61%-7.34M31.66%-5.03M-125.14%-42.19M-190.26%-22.86M27.89%-5.1M-44.07%-6.88M-845.93%-7.35M-9.31%-18.74M31.83%-7.87M-74.24%-7.08M
Minority interest income
Net income attributable to the parent company -6.61%-7.34M31.66%-5.03M-125.14%-42.19M-190.26%-22.86M27.89%-5.1M-44.07%-6.88M-845.93%-7.35M-9.31%-18.74M31.83%-7.87M-74.24%-7.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.61%-7.34M31.66%-5.03M-125.14%-42.19M-190.26%-22.86M27.89%-5.1M-44.07%-6.88M-845.93%-7.35M-9.31%-18.74M31.83%-7.87M-74.24%-7.08M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg